Technology illuminates a shadowy syndrome.
W G
WG
Hardison
D002792:Cholestyramine Resin / Q000627:therapeutic use; D006801:Humans; D008286:Malabsorption Syndromes / Q000175:diagnosis* / Q000188:drug therapy; D012643:Selenium; D013656:Taurocholic Acid / Q000031:analogs & derivatives
D002792:Cholestyramine Resin; D013656:Taurocholic Acid; C033638:23-seleno-25-homotaurocholic acid; D012643:Selenium